JCR分区:JCR分区等级按照学科分为2区和3区。 根据2023年12月最新升级版的中科院SCI分区,分为大类医学三区,小类血液学、免疫学、移植三区。 3.指标分析 ①Transplantation and Cellular Therapy的2023年最新影响因子为3.2。 ②Transplantation and Cellular Therapy的自引率是偏高的),2023年度为15.6%。 ③Transplantati...
期刊邮箱: 投稿网址:https://www.editorialmanager.com/jtct/default.aspx 期刊网址: https://www.journals.elsevier.com/transplantation-and-cellular-therapy 出版商网址: http://www.elsevier.com Transplantation and Cellular Therapy《移植与细胞治疗》(原:BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION) (官网投...
Transplantation and Cellular Therapy《移植与细胞治疗》(原:BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION) 国际标准刊号:ISSN2666-6367;E-ISSN1523-6536 核心类别:SCIE(2022版), 外文期刊, 投稿网址:editorialmanager.com/jt 期刊网址:journals.elsevier.com/t 所属分区:2区 是否TOP:非TOP期刊 是否综述:非综述期刊...
Transplantation And Cellular Therapy由Elsevier出版商出版,收稿方向涵盖Medicine - Hematology全领域,此刊是中等级别的SCI期刊,所以过审相对来讲不是特别难,但是该刊专业认可度不错,仍然是一本值得选择的SCI期刊 。平均审稿速度 ,影响因子指数3.6,该期刊近期没有被列入国际期刊预警名单,广大学者值得一试。中科院分区(数...
基本信息 期刊全称 Transplantation and Cellular Therapy 期刊简称 Print ISSN Online ISSN 期刊出版社 是否开放获取 Open Access,OA 暂无数据 官网地址 期刊所属领域 期刊简介 JCR分区索引信息2021年数据 是否是SCIE(SCI) 注:SCI已经完全被SCIE取代,参考:SCI被取代 ...
Should CMV monitoring and PET be performed in CMV seropositive autologous HCT recipients receiving CD34-selected grafts? Yes C-II [114,115] NA, not applicable; GI-GVHD, gastrointestinal GVHD; IVIG, intravenous immunoglobulin; PET, preemptive therapy. ⁎ Highest grade = strength of recommendation...
The diagnosis, definitions of resistant and refractory CMV, risk factors, virological genotypes and treatment algorithms are reviewed.doi:10.1016/j.jtct.2021.09.010MK.YongTL.ShigleYJ.KimPA.CarpenterRF.ChemalyGA.PapanicolaouTransplant Cell TherTransplantation and cellular therapy...
Biology of Blood and Marrow Transplantation publishes original research reports, reviews, editorials, commentaries, letters to the editor, and hypotheses and is the official publication of the American Society for Transplantation and Cellular Therapy. The journal focuses on current technology and knowledge...
Cellular Therapy and Transplantation is published since 2009 as an international edition initiated by European specialists in hematology and transplantation. As it used to be, the Journal is aimed for publication of novel results and ideas in the field of transplantation, cellular therapy, hematology ...